Injectable sustained-release hydrogel for high-concentration antibody delivery
There is an increasing interest in subcutaneous (SC) delivery as an alternative to the traditional intravenous (IV) for immunotherapies and other advanced therapies. High-concentration formulations of antibodies are needed to meet the limited-volume requirements of subcutaneous SC delivery. Despite...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Article |
| Language: | English |
| Published: |
Royal Society of Chemistry
2025
|
| Online Access: | https://hdl.handle.net/1721.1/158252 |